Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DHVP | ISIN: SE0009242555 | Ticker-Symbol: 50V
Frankfurt
20.11.24
08:24 Uhr
0,000 Euro
0,000
0,00 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
AINO HEALTH AB Chart 1 Jahr
5-Tage-Chart
AINO HEALTH AB 5-Tage-Chart
GlobeNewswire (Europe)
373 Leser
Artikel bewerten:
(1)

Aino Health AB (publ): Aino Health year-end report January-December 2023

Finanznachrichten News

This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail.

Implemented 100,000 licences. Solid growth according to plan. Improved profitability and cash flow from operations.

October - December 2023

  • Net sales were 6 313 (4 661) TSEK
  • Profit/loss after financial items was SEK -3,851 (-4,440) TSEK
  • Earnings per share were SEK 0 (-0.1)

January - December 2023

  • Net sales were 23 918 (19 908) TSEK
  • Profit/loss after financial items -10 663 (-14 962) TSEK
  • Earnings per share were SEK -0.2 (-0.4)


Dear shareholders,
As we conclude another remarkable year, I am honoured to turn to you with a sense of pride and gratitude for your continued support and commitment to Aino Health. In a year of challenges and opportunities, our unwavering dedication to innovation, resilience and excellence has positioned us for sustainable growth and success.

Operational progress
I am pleased to announce that Aino Health has achieved significant milestones over the last financial year, clearly demonstrating our commitment to delivering value to our shareholders. Our dedicated team has worked tirelessly to strengthen our market position, increase operational efficiency and drive revenue growth.

Financial performance
Despite uncertainties in the global economic environment, Aino Health has delivered improved financial results. Our revenue growth reflects the effectiveness of our strategic initiatives and the resilience of our business model. We have maintained our focus on cost management while making strategic investments for long-term value creation.

Product innovation
Aino Health continues to lead in innovation by introducing cutting-edge solutions that meet the ever-changing needs of our clients. Our commitment to being at the forefront of industry trends ensures that we provide products and services of the highest calibre, strengthening our reputation as a trusted partner in workplace wellness.

Client success stories
Our clients' successes remain at the heart of our business. We are proud to share stories of organisations that have achieved improved employee wellbeing and increased productivity through our solutions. These success stories emphasise the tangible impact Aino Health has on individuals' lives and business performance.

Strategic view
Moving forward, Aino Health is poised for continued growth and success. We remain committed to our strategic priorities, which include:

1. Market expansion We will continue to explore new markets and opportunities to expand our presence. Our goal is to reach more organisations globally and provide them with the tools and resources they need to improve their employees' wellbeing.

2. Technological progress Aino Health is dedicated to being at the forefront of technological advances. We will invest in research and development to ensure our solutions utilise the latest innovations and provide our clients with the highest quality tools to manage workplace health effectively.

3. Client-centred approach Our commitment to understanding and addressing the unique needs of our clients remains unchanged. We will continue to improve our offerings based on client feedback to ensure that Aino Health remains a trusted partner in promoting a healthy and productive workplace. As we reflect on the year's achievements, I would like to express my sincere thanks to our shareholders, clients, employees and partners. Your tireless support and co-operation has been crucial to our success. Moving forward, the Aino Health team looks forward to the opportunities that lie ahead. Together, we will navigate the future with resilience, agility and a shared commitment to making a positive impact on the well-being of individuals and organisations. Thank you for being part of the Aino Health journey

The information contained herein is such as shall be made public by Aino Health AB (publ), in accordance with the EU Market Abuse Regulation. This information was made public, through the agency of Jyrki Eklund, CEO and President of Aino Health AB, at 08.30 AM CET on february 23, 2024.

For more information
Jyrki Eklund
CEO Aino Health
Phone: +358 40 042 4221
jyrki.eklund@ainohealth.com

Certified adviser
Carnegie Investment Bank AB (publ)
For more information see: https://investors.ainohealth.com/certified-adviser/

About Aino Health (publ)
Aino Health is the leading provider of Software as a Service solutions in Corporate Health Management.
The company's complete system of SaaS platforms and services reduces sick leave, lowers related costs and improves business outcomes through increased productivity and employee engagement by making health, well-being and safety an integral part of daily work. For more information visit ainohealth.com.

Link to the report
https://investors.ainohealth.com/rapporter-och-dokument/


© 2024 GlobeNewswire (Europe)
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.